These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29948742)

  • 1. Appropriateness of vancomycin therapeutic drug monitoring and its outcomes among non-dialysis patients in a tertiary hospital in Singapore.
    Seng JJB; Yong MHA; Peh ZX; Soong JL; Tan MH
    Int J Clin Pharm; 2018 Oct; 40(5):977-981. PubMed ID: 29948742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing the Time of Blood Collection to Determine Vancomycin Concentrations in Intensive Care Unit Patients.
    Hammond DA; James TB; Atkinson LN; Painter JT; Lusardi K
    Crit Care Nurse; 2018 Feb; 38(1):24-28. PubMed ID: 29437075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short term impact of guidelines on vancomycin dosing and therapeutic drug monitoring.
    Swartling M; Gupta R; Dudas V; Guglielmo BJ
    Int J Clin Pharm; 2012 Apr; 34(2):282-5. PubMed ID: 22331444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Effectiveness of Dose Individualization to Achieve Therapeutic Vancomycin Concentrations.
    Abulfathi AA; Chirehwa M; Rosenkranz B; Decloedt EH
    J Clin Pharmacol; 2018 Sep; 58(9):1134-1139. PubMed ID: 29746714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Retrospective Review of the Efficiency of First-Dose Therapeutic Drug Monitoring of Gentamicin, Amikacin, and Vancomycin in the Pediatric Population.
    Lim WXS; Chua WBB; Chua JM; Lee Q; Chan JW; Sultana R; Poh BH
    J Clin Pharmacol; 2020 Jan; 60(1):7-15. PubMed ID: 31448430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of serum vancomycin concentration monitoring in patients with hematologic malignancies.
    Fernández de Gatta MD; Calvo MV; Hernández JM; Caballero D; San Miguel JF; Domínguez-Gil A
    Clin Pharmacol Ther; 1996 Sep; 60(3):332-40. PubMed ID: 8841156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin administration: the impact of multidisciplinary interventions.
    Crowley RK; Fitzpatrick F; Solanki D; FitzGerald S; Humphreys H; Smyth EG
    J Clin Pathol; 2007 Oct; 60(10):1155-9. PubMed ID: 17293388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research of optimal dosing regimens and therapeutic drug monitoring for vancomycin by clinical pharmacists: analysis of 7-year data].
    Xu G; Chen E; Mao E; Che Z; He J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):640-645. PubMed ID: 30045790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Level of evidence for therapeutic drug monitoring of vancomycin].
    Jelassi ML; Benlmouden A; Lefeuvre S; Mainardi JL; Billaud EM;
    Therapie; 2011; 66(1):29-37. PubMed ID: 21466775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferable timing of therapeutic drug monitoring in patients with impaired renal function treated with once-daily administration of vancomycin.
    Takahashi Y; Takesue Y; Takubo S; Ishihara M; Nakajima K; Tsuchida T; Ikeuchi H; Uchino M
    J Infect Chemother; 2013 Aug; 19(4):709-16. PubMed ID: 23345049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Treatment Courses When Vancomycin Is Given Every 8 Hours in Adult Patients.
    Brumer E; Dubrovskaya Y; Scipione MR; Aberle C; Rahimian J; Papadopoulos J
    J Pharm Pract; 2015 Dec; 28(6):511-7. PubMed ID: 25112304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Appropriateness of an Initial Dosing Regimen of Vancomycin and Development of a New Dosing Nomogram.
    Yoon S; Park KR; Lee S; Song SH; Park WB; Jang IJ; Yu KS
    Basic Clin Pharmacol Toxicol; 2018 Feb; 122(2):233-238. PubMed ID: 28834212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic monitoring of vancomycin in routine clinical practice].
    Kacířová I; Grundmann M
    Vnitr Lek; 2014 Oct; 60(10):846-51. PubMed ID: 25382007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis.
    Zelenitsky SA; Ariano RE; McCrae ML; Vercaigne LM
    Clin Infect Dis; 2012 Aug; 55(4):527-33. PubMed ID: 22573855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pitfalls in TDM of antibiotic drugs: analytical and modelling issues.
    Neef C; Touw DJ; Harteveld AR; Eerland JJ; Uges DR
    Ther Drug Monit; 2006 Oct; 28(5):686-9. PubMed ID: 17038886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of therapeutic drug monitoring criteria in a computerized prescriber-order-entry system on the appropriateness of vancomycin level orders.
    Traugott KA; Maxwell PR; Green K; Frei C; Lewis JS
    Am J Health Syst Pharm; 2011 Feb; 68(4):347-52. PubMed ID: 21289330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of vancomycin therapeutic usage and trough levels monitoring.
    Kabbara WK; El-Khoury G; Chamas NR
    J Infect Dev Ctries; 2018 Nov; 12(11):978-984. PubMed ID: 32012127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of therapeutic drug monitoring in patients receiving vancomycin.
    Iwamoto T; Kagawa Y; Kojima M
    Biol Pharm Bull; 2003 Jun; 26(6):876-9. PubMed ID: 12808304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observational clinical study on the effects of different dosing regimens on vancomycin target levels in critically ill patients: Continuous versus intermittent application.
    Tafelski S; Nachtigall I; Troeger U; Deja M; Krannich A; Günzel K; Spies C;
    J Infect Public Health; 2015; 8(4):355-63. PubMed ID: 25794497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practice guidelines for therapeutic drug monitoring of vancomycin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring.
    Matsumoto K; Takesue Y; Ohmagari N; Mochizuki T; Mikamo H; Seki M; Takakura S; Tokimatsu I; Takahashi Y; Kasahara K; Okada K; Igarashi M; Kobayashi M; Hamada Y; Kimura M; Nishi Y; Tanigawara Y; Kimura T
    J Infect Chemother; 2013 Jun; 19(3):365-80. PubMed ID: 23673472
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.